LITTLE FALLS, N.J., Sept. 10 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the UBS Global Life Sciences Conference. The formal presentation is scheduled for 9:00 AM ET on Tuesday, September 22, 2009 at the Grand Hyatt New York, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the company's website: www.cantelmedical.com.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For more information please visithttp://www.cantelmedical.com
|SOURCE Cantel Medical Corp.|
Copyright©2009 PR Newswire.
All rights reserved